Who founded ChromaDex?

ChromaDex was founded by Frank Jaksch, Frank L. Jaksch, Jr. in 1999.

Who are ChromaDex's investors?

ChromaDex's investors include Horizons Ventures, WELL Ventures.

How much funding has ChromaDex raised?

ChromaDex has disclosed $103.7M raised across 13 rounds.

Where is ChromaDex headquartered?

ChromaDex is headquartered in Irvine, US.

ChromaDex

NASDAQ: NAGE

Irvine, US · Founded 1999 · Delaware corporation · 143 employees on LinkedIn · 2 known investors

Find your way into ChromaDex

302 people in our graph share verified history with the ChromaDex team — schools, employers, funds. One of them is your warm intro.

Deep Nisharunlockedknows Thomas C. Varvaro · together at University of Illinois Urbana-Champaign (overlapped)

×3knows the team · via University of Illinois Urbana-Champaign

×2knows the team · via Bolt Threads

×4knows the team · via Gies College of Business - University of Illinois Urbana-Champaign

×2knows the team · via Valparaiso University

ChromaDex supplies phytochemical reference standards and botanical reference materials used for research, method development, quality control, and regulatory compliance in the natural products industry. Its catalogue of over 2,000 phytochemical standards serves the pharmaceutical, dietary supplement, food, beverage, cosmetic, and life science sectors, and it is now part of the LGC Standards portfolio.

Biotech Healthtech New Materials

Founders & leadership

ChromaDex was founded in 1999 by Frank Jaksch and Frank L. Jaksch, Jr..

Frank Jaksch inCo-Founder & Chairman of the BoardFrank Jaksch has over 25 years of experience in life sciences and the food, beverage, and dietary supplement industries, with background in leading technology and scientific teams. He founded ChromaDex and serves on the board of Ayana Bio.

Frank L. Jaksch, Jr.Chief Scientific Officer

Troy Rhonemus inEVP2017–2018Troy Rhonemus is Chief Operating Officer at ChromaDex, where he oversees operations, quality, R&D, and regulatory functions. He has built experience managing cross-functional teams and developing supply chains and operational strategies for manufacturing and product commercialization.

Thomas C. Varvaro inCFO2004–2018Thomas C. Varvaro served as Chief Financial Officer, Treasurer, and Secretary of ChromaDex, a supplier of phytochemical reference standards and botanical materials for pharmaceutical, dietary supplement, and life science research. He brought over 27 years of experience in finance, accounting, and business operations, with prior involvement in company restructuring, acquisitions, and investor relations.

Jeffrey HimmelChief Executive Officer

Board

Hugh DunkerleyBoard director

Glenn L. HalprynBoard director

Michael BrauserBoard director

Mark S. GermainBoard director

Barry HonigBoard director

Reid DabneyBoard director

Jeff 10005 Muirlands Blvd., Suite G Baxter inBoard MemberPresident and Chief Executive Officer at VBI Vaccines

Investors · 2

Horizons VenturesHong Kong · $1M – $110M

WELL VenturesreportedVancouvervia Hamed Shahbazi · board

Reported raises · per SEC filings

Form D private placements

$103.7M disclosed across 13 rounds · 2012–2022

▶$3.1MraisedOct 2022 · 3 investors · Biotechnology

Rule 506(b)